ImageneBio (IMA) Depreciation and Depletion (2020 - 2025)

ImageneBio has disclosed Depreciation and Depletion across 6 years of filings, most recently posting $87000.0 for Q2 2025.

• Depreciation and Depletion for Q2 2025 came in at $87000.0, down 5.43% year-over-year; the trailing twelve-month figure through Jun 2025 was $353000.0 (down 57.88% YoY), and the FY2024 annual result was $490000.0, down 51.0% from the prior year.
• Depreciation and Depletion came in at $87000.0 for Q2 2025 at ImageneBio, roughly flat from $87000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $285000.0 in Q4 2023 to a low of $87000.0 in Q1 2025.
• The 5-year median for Depreciation and Depletion is $155500.0 (2021), against an average of $159888.9.
• Across the five-year window, Depreciation and Depletion surged 113.0% in 2022 and plunged 68.77% in 2024, its largest moves.
• ImageneBio's Depreciation and Depletion stood at $163000.0 in 2021, then advanced by 28.83% to $210000.0 in 2022, then surged by 35.71% to $285000.0 in 2023, then slumped by 68.77% to $89000.0 in 2024, then fell by 2.25% to $87000.0 in 2025.
• The last three Depreciation and Depletion figures came in at $87000.0 (Q2 2025), $87000.0 (Q1 2025), and $89000.0 (Q4 2024), per Business Quant data.